Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP437845.RA3MxtmAVeJojKRv-QRWFLeOkW23ajywL5j5TcCHCY9uQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP437845.RA3MxtmAVeJojKRv-QRWFLeOkW23ajywL5j5TcCHCY9uQ130_assertion type Assertion NP437845.RA3MxtmAVeJojKRv-QRWFLeOkW23ajywL5j5TcCHCY9uQ130_head.
- NP437845.RA3MxtmAVeJojKRv-QRWFLeOkW23ajywL5j5TcCHCY9uQ130_assertion description "[These observations suggest that the NAT1*11 variant and the GSTM1 wild-type genotype contribute to a more favorable outcome in patients treated for neuroblastoma and are the first to demonstrate a relationship between NAT1 and GSTM1 genotypes in childhood neuroblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP437845.RA3MxtmAVeJojKRv-QRWFLeOkW23ajywL5j5TcCHCY9uQ130_provenance.
- NP437845.RA3MxtmAVeJojKRv-QRWFLeOkW23ajywL5j5TcCHCY9uQ130_assertion evidence source_evidence_literature NP437845.RA3MxtmAVeJojKRv-QRWFLeOkW23ajywL5j5TcCHCY9uQ130_provenance.
- NP437845.RA3MxtmAVeJojKRv-QRWFLeOkW23ajywL5j5TcCHCY9uQ130_assertion SIO_000772 17700360 NP437845.RA3MxtmAVeJojKRv-QRWFLeOkW23ajywL5j5TcCHCY9uQ130_provenance.
- NP437845.RA3MxtmAVeJojKRv-QRWFLeOkW23ajywL5j5TcCHCY9uQ130_assertion wasDerivedFrom befree-20150227 NP437845.RA3MxtmAVeJojKRv-QRWFLeOkW23ajywL5j5TcCHCY9uQ130_provenance.
- NP437845.RA3MxtmAVeJojKRv-QRWFLeOkW23ajywL5j5TcCHCY9uQ130_assertion wasGeneratedBy ECO_0000203 NP437845.RA3MxtmAVeJojKRv-QRWFLeOkW23ajywL5j5TcCHCY9uQ130_provenance.